期刊文献+

β受体阻滞剂对永久起搏器植入患者左室收缩功能的影响 被引量:2

Effect of β-blockers on ventricular function in patients in pacemaker-dependent with heart failure
下载PDF
导出
摘要 目的观察β受体阻滞剂在治疗心衰患者时对左室收缩功能的影响。方法将安装起博器有心衰症状的左室收缩功能障碍的68例患者,起博频率调整为60次/分并随机均分为两组,治疗组34例在接受ACEI或ARB,氨体舒通治疗稳定的基础上加用β受体阻滞剂治疗;对照组34例接受ACEI或ARB,氨体舒通治疗;疗程为9个月,治疗前后行心脏彩色多普勒检查,测量左室射血分数。结果治疗组与对照组比较,治疗组显著提高平均左室射血分数(P=0.002)。结论在不改变心率的条件下,β受体阻滞剂在治疗心衰患者时可维持左心室收缩功能。 Objective To evaluated the effect on ventricular function in patients with heart failure treated with β-blockers.Methods 68 patients in pacemaker-dependent patients with symptomatic left ventricular(LV) systolic dysfunction seted pacing rate at 60 ppm.34 patients treated by angiotensin-converting enzyme inhibitors or angiotensin receptor blockers,β-blockers,and spironolactone.Other 34 patients treated by angiotensin-converting enzyme inhibitors or angiotensin receptor blockers,and spironolactone.Gated Doppler echocardiography was performed at baseline and after at least 9 months.The primary outcome was change in LVEF,from baseline to follow-up.Results Compared with no β-blockers treatment,34 patients with β-blockers treatment showed an increase in LV ejection fraction(P=0.002 for the difference between groups).Conclusion β-blockers are effective for treatment of heart failure.
出处 《西部医学》 2011年第12期2347-2348,共2页 Medical Journal of West China
关键词 心力衰竭 Β受体阻滞剂 治疗 Heart failure β-Blocker therapy
  • 相关文献

参考文献10

  • 1Cleland JGF, Bristow M, Erdmann E, et al. Beta-blocking agents in heart failure: should they be used and how[J]. Eur Heart J, 1996,17 : 1629-1639. 被引量:1
  • 2Doughty RN, Whalley GA, Gamble G, et al. On behalf of the Australia and New-Zealand heart failure research collaborative group: left ventricular remodelling with earvedilol in patients with congestive heart failure due to ischaemie heart disease[J]. Jaec, 1997,29 : 1060-1066. 被引量:1
  • 3Dubach P, Myers J, Bonetti P, et al. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging[J]. Am Heart J, 2002,143:676-683. 被引量:1
  • 4Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts[J]. N Engl J Med, 1982,307:205-211. 被引量:1
  • 5Lowes BD, Gilbert EM, Abraham WT, et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents[J]. N Engl J Med, 2002,346:1357-1365. 被引量:1
  • 6Poole-Wilson PA, Swedberg K, Cleland .IG, ee al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET) : randomised controlled trial[J]. Lancet, 2003, 362:7-13. 被引量:1
  • 7Nagatsu M, Spinale FG, Koide M, et al. Bradycardia and the role of p-blockade in the amelioration of left ventricular dysfunction[J]. Circulation, 2000,101:653-659. 被引量:1
  • 8Ciee G, Tagliamonte E, Ferrara L, et al. Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study [J]. Eur Heart J, 2000,21:1259-1264. 被引量:1
  • 9Cleland JG, Pennell DJ, Ray SG, et al. Carvedilol hibernating reversible ischaemia trial: marker of success investigators. Myocardial viability as a determinant of the ejection fraction response to carveditol in patients with heart failure (CHRISTMAS trial) : randomised controlled trial[J]. Lancet, 2003,362 : 14-21. 被引量:1
  • 10Jourdain P, Funck F, Fulla Y, et al. Myocardial contractile reserve under low doses of dobutamine and improvement of left ventrieular ejection fraction with treatment by carvedilol[J]. Eur J Heart Fail, 2002,4:269-276. 被引量:1

同被引文献24

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部